STAAR Surgical Company (FRA:SR3)

Market Cap	749.84M -32.9%
Revenue (ttm)	197.20M -32.4%
Net Income	-82.41M
EPS	-1.67
Shares Out	n/a
PE Ratio	n/a
Forward PE	34.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	4
Open	15.13
Previous Close	14.83
Day's Range	15.13 - 15.28
52-Week Range	13.44 - 24.46
Beta	n/a
RSI	45.63
Earnings Date	Feb 20, 2026

About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors...

• Industry: Ophthalmic Goods
• Founded: 1982
• Employees: 1,157
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SR3

Financial Performance

Financial numbers in USD